We are happy to announce that we are sponsoring BioTechX this year, one of Europe's largest biopharma congresses. It will be held this year from November 8-10 at Basel Congress Center, Switzerland. Come and meet us at booth #56 and find out how we can help you lower the risks and time frames in preclinical drug discovery!
Come to our booth and find out how we predict novel gene-disease associations to drive your drug discovery pipeline. Try out our disease predictor and see one of our top 20 predictions for your gene of interest. Delve deeper using our AI-integrated knowledge base!
Kees Albers, our Chief Scientific Officer will be speaking on Wednesday, November 9th @ 15:30. The topic will be 'The Euretos approach for target identification and indication selection'; An incomplete understanding of the molecular basis of the disease is a challenge for drug discovery. Many true gene-disease associations may go undetected due to inherent shortcomings of study design or lack of statistical power, despite increasingly large studies.
Euretos has developed a rational, data-driven approach for target discovery and indication selection that uncovers hidden gene-disease associations.
You are cordially invited to attend the talk and learn more about our approach or visit Kees and other experts at our booth!
.svg)
